Skip to main content

Cromolyn Sodium in the Treatment of Asthma

Buy Article:

$39.50 plus tax (Refund Policy)


Cromolyn sodium has been available as a first-line agent for the prevention of acute paroxysms of asthma for over 15 years, and a large body of information regarding its utility has appeared in the literature. Despite this experience, however, many physicians still remain confused as to the most appropriate circumstances in which to use the drug, and so can not predict the patient most apt to derive maximum benefit. The purpose of the present review is to summarize briefly those situations in which cromolyn is of proven effectiveness and to present the current concepts regarding its mechanism of action.

Document Type: Research Article


Affiliations: Associate Professor of Medicine, Director of Research, Shipley Institute of Medicine, Brigham and Women's Hospital, Boston

Publication date: 1983-06-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more